organ rejection

Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of…

Duke University doctors say a baby is thriving after a…

Nephrologists now can predict the starting dose using the genetic profile of the patient. (Representative Image)Immunosuppressant drugs are prescribed to kidney, heart or liver transplant…